FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to an interferon-containing composition for the treatment of chronic polypous rhinosinusitis. Interferon-containing composition for the treatment of chronic polypous rhinosinusitis, containing recombinant interferon, acid and water, characterized in that it contains interferon α2b AND/OR gamma (γ) as an interferon, and contains succinic acid as an acid, while additionally dimethyl sulfoxide and chitosan in the following the content of components: interferon alpha and/or gamma - 0.5-1.5 million IU, succinic acid - 0.1-1.2 wt. %, chitosan - 0.1–1.0 wt. %, dimethyl sulfoxide - 0.01–0.1 wt. %, water - the rest in wt.%.
EFFECT: invention allows to increase the delay time of interferon in the nasal mucosa and reduce its entry into the systemic circulation.
1 cl, 8 dwg, 14 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION BASED ON INTERFERON I OR III TYPE AND GAMMA-D-GLUTAMINYL-L-TRYPTOPHAN FOR PREVENTION AND TREATMENT OF INFECTIOUS DISEASES AND IMMUNODEFICIENCY CONDITIONS (OPTIONS) | 2014 |
|
RU2672861C2 |
ANTI-RADIATION COMPOSITION BASED ON CHITINO-GLUCAN COMPLEX OF OYSTER MUSHROOMS | 2022 |
|
RU2804298C1 |
CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
METHOD OF TREATING INFECTIONS INDUCED BY HERPES SIMPLEX VIRUSES TYPE I AND II, CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS | 2008 |
|
RU2391981C2 |
DRUG FOR RESPIRATORY INFECTIOUS DISEASES GLUCAFERON | 2011 |
|
RU2450812C1 |
INTERFERON-CONTAINING AEROSOL COMPOSITION "NIKOFEN" | 2004 |
|
RU2277904C2 |
METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
METHOD FOR TREATING PATIENTS WITH ALLERGIC RHINITIS ASSOCIATED WITH CHRONIC RHINOSINUSITIS OF BACTERIAL ETIOLOGY USING A DOMESTICALLY PRODUCED TOPICAL IMMUNE CORRECTOR | 2020 |
|
RU2760825C1 |
METHOD FOR PREDICTING THE EFFICIENCY OF THERAPY WITH INTERLEUKIN-1 | 2005 |
|
RU2301012C2 |
METHOD OF TREATING CHRONIC RHINOSINUSITIS | 2011 |
|
RU2469737C1 |
Authors
Dates
2023-02-06—Published
2022-05-24—Filed